HU210882A9 - Method for the treatment of thrombocytopenia and pharmaceutical compositions useful therefor - Google Patents

Method for the treatment of thrombocytopenia and pharmaceutical compositions useful therefor

Info

Publication number
HU210882A9
HU210882A9 HU95P/P00136P HU9500136P HU210882A9 HU 210882 A9 HU210882 A9 HU 210882A9 HU 9500136 P HU9500136 P HU 9500136P HU 210882 A9 HU210882 A9 HU 210882A9
Authority
HU
Hungary
Prior art keywords
pct
thrombocytopenia
treatment
pharmaceutical compositions
compositions useful
Prior art date
Application number
HU95P/P00136P
Other languages
English (en)
Inventor
Donald Metcalf
Original Assignee
Amrad Corp Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amrad Corp Ltd filed Critical Amrad Corp Ltd
Publication of HU210882A9 publication Critical patent/HU210882A9/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2093—Leukaemia inhibitory factor [LIF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HU95P/P00136P 1989-12-18 1995-05-19 Method for the treatment of thrombocytopenia and pharmaceutical compositions useful therefor HU210882A9 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPJ791289 1989-12-18
AUPK350190 1990-11-23

Publications (1)

Publication Number Publication Date
HU210882A9 true HU210882A9 (en) 1995-09-28

Family

ID=25643793

Family Applications (2)

Application Number Title Priority Date Filing Date
HU9202026A HUT61485A (en) 1989-12-18 1990-12-18 Process for producing drug composition suitable for treating thrombocytopenia
HU95P/P00136P HU210882A9 (en) 1989-12-18 1995-05-19 Method for the treatment of thrombocytopenia and pharmaceutical compositions useful therefor

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HU9202026A HUT61485A (en) 1989-12-18 1990-12-18 Process for producing drug composition suitable for treating thrombocytopenia

Country Status (12)

Country Link
US (1) US5571508A (hu)
EP (1) EP0506716B1 (hu)
JP (1) JP2574962B2 (hu)
AT (1) ATE128871T1 (hu)
CA (1) CA2071956C (hu)
DE (1) DE69023006T2 (hu)
DK (1) DK0506716T3 (hu)
ES (1) ES2078501T3 (hu)
FI (1) FI922839A0 (hu)
GR (1) GR3017727T3 (hu)
HU (2) HUT61485A (hu)
WO (1) WO1991008752A1 (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1315870C (zh) 1995-06-07 2007-05-16 葛兰素集团有限公司 结合血小板生成素受体的肽和化合物
US6251864B1 (en) 1995-06-07 2001-06-26 Glaxo Group Limited Peptides and compounds that bind to a receptor
US5869451A (en) * 1995-06-07 1999-02-09 Glaxo Group Limited Peptides and compounds that bind to a receptor
US7091311B2 (en) 1996-06-07 2006-08-15 Smithkline Beecham Corporation Peptides and compounds that bind to a receptor
ES2462916T3 (es) 2002-09-18 2014-05-26 Janssen Pharmaceuticals, Inc. Métodos para aumentar la producción de células madre hematopoyéticas y plaquetas
SI1675606T1 (sl) 2003-08-28 2017-07-31 Janssen Pharmaceuticals, Inc. Peptidi in spojine, ki se vežejo na trombopoietinske receptorje
US7723295B2 (en) 2003-08-28 2010-05-25 Ortho-Mcneil Pharmaceutical, Inc. Peptides and compounds that bind to a receptor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4859648A (en) * 1984-12-28 1989-08-22 Mobil Oil Corporation Layered metal chalcogenides containing interspathic polymeric chalcogenides
AU609128B2 (en) * 1987-04-02 1991-04-26 Amrad Operations Pty. Limited Leukaemia-inhibitory factor
WO1990002183A1 (en) * 1988-08-18 1990-03-08 Genetics Institute, Inc. Production of a novel lymphokine exhibiting differentiation inhibitory activity
JP2805224B2 (ja) * 1989-01-13 1998-09-30 味の素株式会社 血小板減少症治療剤
JP3040815B2 (ja) * 1989-11-24 2000-05-15 モナッシュ・ユニバーシティ 随伴細胞に及ぼす白血病抑制因子の増殖作用

Also Published As

Publication number Publication date
HU9202026D0 (en) 1992-09-28
ES2078501T3 (es) 1995-12-16
EP0506716A1 (en) 1992-10-07
JPH05502667A (ja) 1993-05-13
DE69023006D1 (de) 1995-11-16
JP2574962B2 (ja) 1997-01-22
CA2071956C (en) 2000-04-18
CA2071956A1 (en) 1991-06-19
DK0506716T3 (da) 1996-02-26
AU6910491A (en) 1991-07-18
US5571508A (en) 1996-11-05
FI922839A (fi) 1992-06-17
EP0506716B1 (en) 1995-10-11
ATE128871T1 (de) 1995-10-15
HUT61485A (en) 1993-01-28
EP0506716A4 (en) 1993-05-05
AU644834B2 (en) 1993-12-23
DE69023006T2 (de) 1996-04-11
GR3017727T3 (en) 1996-01-31
FI922839A0 (fi) 1992-06-17
WO1991008752A1 (en) 1991-06-27

Similar Documents

Publication Publication Date Title
EP0528858A4 (en) Inhibitors of dipeptidyl-aminopeptidase type iv
MY111556A (en) Substituted azadioxacycloalkenes.
DE69401204D1 (de) Gonadotropin enthaltende gefriergetrocknete troepfen
RU94046291A (ru) Способ профилактики и лечения периферической невропатии, композиция, содержащая инсулин-подобный фактор роста i
NO952321D0 (no) Polypeptid, samt anti-HIV-preparat fremstilt fra dette
ATE185548T1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
DK0589995T3 (da) Hidtil ukendte polypeptider og deres anvendelse
IL126235A (en) Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use
HU210882A9 (en) Method for the treatment of thrombocytopenia and pharmaceutical compositions useful therefor
GR3034142T3 (en) Composition for the treatment or prevention of herpes
HU9201267D0 (en) Method for producing pharmaceutical preparatives containing gfi
EP0620736A4 (en) A method for the treatment of tumours and sarcomas.
MY107258A (en) 1-methoxypyrimidinyl-n-nitrophenyl-1h-1,2,4-triazole-3- sulphonamides, processes for their preparation and their use as herbicides.
GB9015774D0 (en) Novel treatment
NO922341L (no) Fremgangsmaate og middel for behandling av trombocytopeni
ZA939227B (en) Novel triazoloquinazolines,their preparation and use
ATE232724T1 (de) Inhibitor von stickstoffmonoxid (no) synthase zur verhütung von typ ii diabetes
MY102564A (en) An indole derivative
SE9304065D0 (sv) New compound